Document Type : Original Article
Authors
- Narayanan Subramanian 1
- Debajyoti Bhattacharyya 2
- Inam Danish Khan 1
- Vishnu Prasad 1
- Arun Kotaru 3
- Vasu Vardhan 4
- Kapil Pandya 1
1 Army College of Medical Sciences and Base Hospital, New Delhi, India
2 Army Hospital Research and Referral, New Delhi, India
3 Venkateshwara Hospital, Dwarka, New Delhi, India
4 Armed Forces Medical College, Pune, India
Abstract
Background: Tuberculous, parapneumonic and traumatic loculated pleural-effusions pose therapeutic challenges due to resultant pleural-thickening and compromised lung-function for life. Tuberculosis is widely prevalent in developing countries, necessitating appropriate, effective, and economical treatment for loculated pleural-effusion to reduce the burden and sequelae.
Objective: An uncontrolled and blind before-after intervention study to determine the effectiveness of intrapleural fibrinolytic therapy (IPFT) using urokinase in loculated pleural effusions was conducted at a tertiary-care respiratory center after obtaining approval and written informed consent.
Methods: Fifty-one patients with loculated pleural effusion were administered with repeated cycles of three doses of 1 Lakh IU of urokinase intrapleurally until complete drainage of pleural fluid. Pre- and post-IPFT clinical and radiological responses were compared using removal of fluid, ultrasound, and chest radiography were compared. The Kolmogorov-Smirnov test and paired t test with significance at a P value less than 0.05 were applied to test statistically significant differences in proportions and means, respectively.
Results: Tuberculosis was the most common etiology leading to loculated pleural effusion (80%), and 82.4% of tuberculosis patients required at least two cycles of IPFT. Complete resolution in chest radiograph after IPFT was observed in 80.4% of patients. Chest pain (13.7%) and fever (9.8%) were the most common undesired effects associated with IPFT. A statistically significant reduction in mean intrapleural fluid levels pre- and post-IPFT from 184±81 ml to 67±52 ml was observed.
Conclusion: IPFT with urokinase is an effective treatment modality in patients with post-tubercular loculated pleural effusions. IPFT has minimal and tolerable undesired effects and prevents sequelae such as pleural thickening and consequent compromise of respiratory function.
Keywords
- Mason RJ, Broaddus VC, Martin TR, et al. Murray and Nadel’s Textbook of Respiratory Medicine. Elsevier Health Sciences; 2010.
- Idell S. The pathogenesis of pleural space loculation and fibrosis. Curr Opin Pulm Med. 2008;14(4):310-315. doi:10.1097/MCP.0b013e3282fd0d9b.
- Vorster MJ, Allwood BW, Diacon AH, Koegelenberg CF. Tuberculous pleural effusions: advances and controversies. J Thorac Dis. 2015;7(6):981-991. doi:10.3978/j.issn.2072-1439.2015.02.18.
- Light RW. Update on tuberculous pleural effusion. Respirology. 2010;15(3):451-458. doi:10.1111/j.1440-1843.2010.01723.x.
- Sahni AK, Singh SP, Kumar A, Khan ID. Comparison of IS6110 and ‘short fragment’ devR (Rv3133c) gene targets with phenotypic methods for diagnosis of Mycobacterium tuberculosis. Med J Armed Forces India. 2013;69(4):341-344. doi:10.1016/j.mjafi.2013.02.003.
- Khan ID, Sahni AK, Bharadwaj R, Lall M, Jindal AK, Sashindran VK. Emerging organisms in a tertiary healthcare set up. Med J Armed Forces India. 2014;70(2):120-128. doi:10.1016/j.mjafi.2013.09.005.
- Khan ID, Lall M, Sen S, Ninawe SM, Chandola P. Multiresistant Elizabethkingia meningoseptica infections in tertiary care. Med J Armed Forces India. 2015;71(3):282-286. doi:10.1016/j.mjafi.2014.02.002.
- Khan ID, Rajmohan KS, Gupta RM, et al. Invasive Cerebral and Pulmonary Mucormycosis in an Immunocompromised patient. J Basic Clin Med. 2017;6(2):9-11.
- Khan ID, Basu A, Kiran S, Trivedi S, Pandit P, Chattoraj A. Device-Associated Healthcare-Associated Infections (DA-HAI) and the caveat of multiresistance in a multidisciplinary intensive care unit. Med J Armed Forces India. 2017;73(3):222- 231. doi:10.1016/j.mjafi.2016.10.008.
- Chung CL, Chen CH, Yeh CY, Sheu JR, Chang SC. Early effective drainage in the treatment of loculated tuberculous pleurisy. Eur Respir J. 2008;31(6):1261-1267. doi:10.1183/09031936.00122207.
- Abusedera M, Alkady O. Ultrasound-guided Pleural Effusion Drainage With a Small Catheter Using the Single-step Trocar or Modified Seldinger Technique. J Bronchology Interv Pulmonol. 2016;23(2):138-145. doi:10.1097/LBR.0000000000000276.
- Cantin L, Chartrand-Lefebvre C, Lepanto L, et al. Chest tube drainage under radiological guidance for pleural effusion and pneumothorax in a tertiary care university teaching hospital: Review of 51 cases. Can Respir J. 2005;12(1):29-33. doi:10.1155/2005/498709.
- Khan ID, Sahni AK. Rapid Diagnosis of Dengue Outbreaks in Resource Limited Facilities. West Indian Med J. 2017;66(1):4-9. doi:10.7727/wimj.2016.095.
- Sherry S, Johnson A, Tillett WS. The action of streptococcal desoxyribose nuclease (streptodornase)in vitro and on purulent pleural exudations of patients. J Clin Invest. 1949;28(5 Pt 2):1094-1104. doi:10.1172/JCI102142.
- Tillett WS, Sherry S, Read CT. The use of streptokinase-streptodornase in the treatment of postneumonic empyema. J Thorac Surg. 1951;21(3):275-297.
- Maskell NA, Davies CW, Nunn AJ, et al. U.K. Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med. 2005;352(9):865-874. doi:10.1056/NEJMoa042473.
- Balfour-Lynn IM, Abrahamson E, Cohen G, et al. BTS guidelines for the management of pleural infection in children. Thorax. 2005;60 Suppl 1:i1-21. doi:10.1136/thx.2004.030676.
- Cases Viedma E, Lorenzo Dus MJ, Gonzalez-Molina A, Sanchis Aldas JL. A study of loculated tuberculous pleural effusions treated with intrapleural urokinase. Respir Med. 2006;100(11):2037-2042. doi:10.1016/j.rmed.2006.02.010.
- Janda S, Swiston J. Intrapleural fibrinolytic therapy for treatment of adult parapneumonic effusions and empyemas: a systematic review and meta-analysis. Chest. 2012;142(2):401-411. doi:10.1378/chest.11-3071.
- Cameron R, Davies HR. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema. Cochrane Database Syst Rev. 2008(2):Cd002312. doi: 10.1002/14651858. CD002312.pub3.
- Abu-Daff S, Maziak DE, Alshehab D, et al. Intrapleural fibrinolytic therapy (IPFT) in loculated pleural effusions--analysis of predictors for failure of therapy and bleeding: a cohort study. BMJ Open. 2013;3(2). doi:10.1136/bmjopen-2012-001887.
- Janda S, Swiston J. Intrapleural fibrinolytic therapy for treatment of adult parapneumonic effusions and empyemas: a systematic review and meta-analysis. Chest. 2012;142(2):401-411. doi:10.1378/chest.11-3071.
- Nie W, Liu Y, Ye J, et al. Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusion: a meta-analysis of randomized control trials. Clin Respir J. 2014;8(3):281-291. doi:10.1111/crj.12068.
- Khan ID, Gupta RM, Sen S, et al. Emerging Antimicrobial Resistance and Evolving Healthcare: Dangerous Crossroads for the Community and the Military. J Arch Mil Med. 2017;5(3):e12097. doi:10.5812/jamm.12097.
- Barthwal MS, Marwah V, Chopra M, et al. A Five-Year Study of Intrapleural Fibrinolytic Therapy in Loculated Pleural Collections. Indian J Chest Dis Allied Sci. 2016;58(1):17-20.
- Khan ID, Gupta N, Rangan NM, et al. Evaluation of Pre and Post Analytical Variables in Clinical Microbiology Services in Multidisciplinary ICU of a Medical College and Tertiary Care Hospital. J Basic Clin Med. 2016;5(1):2-4.
)
